Get the Stockscreener App
1.15
0.86%
-0.01
Bionano Genomics Inc stock is traded at $1.15, with a volume of 126.32K.
It is down -0.86% in the last 24 hours and up +0.00% over the past month.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
See More
Previous Close:
$1.16
Open:
$1.17
24h Volume:
126.32K
Relative Volume:
0.44
Market Cap:
$13.20M
Revenue:
$28.74M
Net Income/Loss:
$-31.60M
P/E Ratio:
-0.2264
EPS:
-5.0805
Net Cash Flow:
$-19.30M
1W Performance:
-0.86%
1M Performance:
+0.00%
6M Performance:
-26.75%
1Y Performance:
-67.51%
1-Day Range:
$1.15
$1.18
1-Week Range:
$1.15
$1.21
52-Week Range:
$1.06
$5.50
Bionano Genomics Inc Stock (BNGO) Company Profile
Name
Bionano Genomics Inc
Sector
Industry
Phone
(858) 888-7600
Address
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Compare BNGO vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BNGO
Bionano Genomics Inc
|
1.15 | 13.31M | 28.74M | -31.60M | -19.30M | -5.0805 |
ISRG
Intuitive Surgical Inc
|
417.07 | 147.53B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
145.16 | 40.10B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
65.84 | 32.33B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
37.09 | 31.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
193.94 | 27.96B | 5.54B | 1.52B | 1.74B | 10.37 |
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-24 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Sep-10-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Dec-12-22 | Resumed | BTIG Research | Buy |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Jun-16-21 | Initiated | BTIG Research | Buy |
| Sep-24-20 | Initiated | Ladenburg Thalmann | Buy |
| Apr-08-20 | Initiated | Oppenheimer | Outperform |
View All
Bionano Genomics Inc Stock (BNGO) Latest News
Bionano Genomics Keeps Penny Stock Risk In Focus - Kalkine Media
Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic Disorders - The Manila Times
Infertility gene clues: 13 studies find hidden variants with Bionano mapping - Stock Titan
BNGO News | BIONANO GENOMICS INC (NASDAQ:BNGO) - ChartMill
Bionano Genomics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plansmoomoo - Moomoo
Bionano Genomics (BNGO) upgraded to buy: What does it mean for the stock? - MSN
Bionano Genomics (BNGO) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
BioNano Genomics Announces Resignation of Chief Medical Officer - The Globe and Mail
Bionano Genomics (NASDAQ: BNGO) Chief Medical Officer to step down - Stock Titan
Bionano Genomics, Inc. Announces Resignation of Alka Chaubey as Chief Medical Officer, Effective July 5, 2026 - marketscreener.com
Bionano appoints board chairman as interim CEO - Investing.com
Bionano Genomics (BNGO) CMO has 24 vested shares withheld for tax obligations - Stock Titan
Bionano Genomics (BNGO) counsel has 24 shares withheld for RSU taxes - Stock Titan
Bionano Genomics (BNGO) officer reports 7-share tax withholding - Stock Titan
Bionano (BNGO) Q1 2026 Earnings Transcript - The Globe and Mail
Bionano Genomics names board chair Luderer interim CEO - MSN
Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO) and BioLife Solutions (BLFS) - The Globe and Mail
Maxim Group Maintains Bionano Genomics(BNGO.US) With Buy Rating, Maintains Target Price $4 - Moomoo
BioNano Genomics Retires Secured Debt, Boosts Flexibility - The Globe and Mail
Bionano Genomics Fully Retires $20 Million Secured Debt, Boosting Financial Flexibility for Future Growth 1 - Minichart
Why fast-paced mover Bionano Genomics (BNGO) is a great choice for value investors - MSN
Why Fast-paced Mover Bionano Genomics (BNGO) Is a Great Choice for Value Investors - Yahoo Finance
Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures - The Manila Times
Bionano fully retires $20M senior secured convertible debentures, frees secured assets - TradingView
Bionano Genomics (NASDAQ: BNGO) eliminates $20M secured debt load - Stock Titan
Bionano clears $20M in secured debt, gains new flexibility - Stock Titan
BNGO Stock Price, Quote & Chart | BIONANO GENOMICS INC (NASDAQ:BNGO) - ChartMill
Bionano Genomics (BNGO) Achieves Breakthrough in T-ALL Detection - GuruFocus
Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia - The Manila Times
Leukemia study: genome scan finds abnormalities in 97.8% of T-ALL cases - Stock Titan
Bionano Genomics Q4 2026 earnings preview - MSN
Optical Genome Mapping Market Size, Share, Growth, Analysis, 2034 - Straits Research
BNGO Q1 2026 Earnings: Narrowing Losses Beat Estimates, but Stock Declines on Uncertain OutlookEarnings Power Value - newsline.com
Earnings call transcript: Bionano Genomics sees Q1 revenue growth, stock edges up - Investing.com Canada
Q1 2026 Bionano Genomics Inc Earnings Call Transcript - GuruFocus
Bionano outlines $30M-$33M 2026 revenue guidance as it expects flow cell supply to improve - MSN
Bionano Genomics, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:BNGO) 2026-05-16 - Seeking Alpha
Bionano Genomics, Inc. (NASDAQ:BNGO) Q1 2026 Earnings Call Transcript - Insider Monkey
Bionano Genomics shareholders elect directors and approve proposals at annual meeting - Investing.com Nigeria
Bionano Genomics (NASDAQ: BNGO) director awarded 9,149 options - Stock Titan
Bionano Genomics (BNGO) director granted 9,149 stock options at $1.19 - Stock Titan
Bionano Genomics (BNGO) director awarded 9,149 stock options vesting over 12 months - Stock Titan
Bionano Genomics (BNGO) director receives grant of 9,149 stock options at $1.19 - Stock Titan
Bionano Genomics (BNGO) director receives stock option grant for 9,149 shares - Stock Titan
BioNano Genomics Stockholders Approve 2026 Annual Meeting Proposals - TipRanks
Bionano Genomics shareholders elect directors and approve proposals at annual meeting By Investing.com - Investing.com South Africa
Bionano Genomics 1Q Rev $6.7M >BNGO - Moomoo
Bionano Genomics Inc Stock (BNGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.68%
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):